Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy
Authors:
- Mohamed A. SoltanMSMohamed A. Soltan
- Muhammad Alaa EldeenMEMuhammad Alaa Eldeen
- Bayan H. SajerBayan H. Sajer
- Reda F. A. AbdelhameedRAReda F. A. Abdelhameed
- Fawziah A. Al-SalmiFAFawziah A. Al-Salmi
- Eman FayadEFEman Fayad
- Ibrahim JafriIJIbrahim Jafri
- Hebatallah Emam Mohammed AhmedHAHebatallah Emam Mohammed Ahmed
- Refaat A. EidRERefaat A. Eid
- Hesham M. HassanHHHesham M. Hassan
- Mubarak Al-ShraimMAMubarak Al-Shraim
- Amr NegmAmr Negm
Open Access
Abstract
Epithelial cell transforming 2 (ECT2) is a potential oncogene and a number of recent studies have correlated it with the progression of several human cancers. Despite this elevated attention for ECT2 in oncology-related reports, there is no collective study to combine and integrate the expression and oncogenic behavior of ECT2 in a panel of human cancers. The current study started with a differential expression analysis of ECT2 in cancerous versus normal tissue. Following that, the study asked for the correlation between ECT2 upregulation and tumor stage, grade, and metastasis, along with its effect on patient survival. Moreover, the methylation and phosphorylation status of ECT2 in tumor versus normal tissue was assessed, in addition to the investigation of the ECT2 effect on the immune cell infiltration in the tumor microenvironment. The current study revealed that ECT2 was upregulated as mRNA and protein levels in a list of human tumors, a feature that allowed for the increased filtration of myeloid-derived suppressor cells (MDSC) and decreased the level of natural killer T (NKT) cells, which ultimately led to a poor prognosis survival. Lastly, we screened for several drugs that could inhibit ECT2 and act as antitumor agents. Collectively, this study nominated ECT2 as a prognostic and immunological biomarker, with reported inhibitors that represent potential antitumor drugs.Keywords
Funding Information
- King Khalid University in Abha, Saudi Arabia (G.R.P.1-290-43, GRANT3201)
- King Faisal University, Saudi Arabia (G.R.P.1-290-43, GRANT3201)
This publication has 115 references indexed in Scilit:
- Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft modelJournal of Materials Science: Materials in Medicine, 2013
- Structural Basis for Autoinhibition of the Guanine Nucleotide Exchange Factor FARP2Structure, 2013
- DNA Methylation Mediated Control of Gene Expression Is Critical for Development of Crown Gall TumorsPLOS Genetics, 2013
- EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylationAmino Acids, 2012
- Modulation of a GEF switch: Autoinhibition of the intrinsic guanine nucleotide exchange activity of p115‐RhoGEFProtein Science, 2010
- The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancerAdvances in Enzyme Regulation, 2010
- Ect2 links the PKCι–Par6α complex to Rac1 activation and cellular transformationOncogene, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- GEFs and GAPs: Critical Elements in the Control of Small G ProteinsCell, 2007